返回 Agenda
Session Chair(s)
Jacqueline Law, PHD
Roche, China
Speaker(s)
Evaluation of Confounding Effect on OS by Non-Protocol Therapies after Disease Progression in Oncology Clinical Trials
Nicole Li, PHD
Roche/Genentech, China
Director of Biostatistics
Treatment Effects on Disease Progression and Overall Survival in Oncology Clinical Trials
Qi Jiang, PHD
Amgen Inc., United States
Executive Director, Global Biostatistical Science
Use of Bayesian Augmented Control Design in Phase II Oncology Clinical Trials
Chao Zhu
Lilly Suzhou Pharmaceutical Co. Ltd., China, China
Head of Medical Science at Lilly China Drug Development and Medical Affairs Cent